Ayman Mahdy

Ayman Mahdy practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Ayman Mahdy's NPI, 1023248911, was assigned on July 26, 2009. Ayman Mahdy graduated from University of Assiut Faculty of Medicine in 1999. Ayman Mahdy holds Ohio license 35.096476.

Ayman Mahdy's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Ayman Mahdy's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. Ayman Mahdy is also affiliated with University of Cincinnati Medical Center. The medical group on file is AdventHealth Medical Group. Dmand AI also links Ayman Mahdy to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ayman Mahdy practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Ayman Mahdy's primary specialty in the NPI Registry, under taxonomy code 208800000X. Ayman Mahdy is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Ayman Mahdy's licenses on file in 5 states: Ohio, Florida, Kentucky, Indiana and Arkansas.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, kidney stones and pelvic prolapse among the conditions Ayman Mahdy treats.

CMS data shows 275 Medicare services from Ayman Mahdy across 9 procedure codes in 2024, for 255 Medicare patients. Medicare paid $27,222 for them.

CMS counts 255 Medicare patients who saw Ayman Mahdy in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ayman Mahdy's median patient age at 64, with 49% women.

In 2024, Ayman Mahdy wrote 581 Medicare Part D claims for 177 patients. 76% of them were for generic drugs. CMS names the drug for 521 of them, across 15 drugs with 11 or more claims each, at $56,080 in total drug cost. In 2023, CMS named 486 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Ayman Mahdy for performance year 2024, reported through an alternative payment model (APM). Ayman Mahdy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ayman Mahdy as offering telehealth. CMS counts 17 procedures of prostate resection by Ayman Mahdy, more than 76% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 44 papers to Ayman Mahdy, published from 2006 to 2024. 2016 was the busiest year, with 6. The most frequent topics are Urinary Incontinence, Stress, Cell Line, Tumor and Ceramides. Ayman Mahdy has published most often in Int Urogynecol J. Ayman Mahdy's most frequent co-authors are Joseph C. Cheng, MD, Akwasi Afriyie Boateng, MD and Guillermo H. Davila, MD.

Dmand AI links Ayman Mahdy to 1 clinical trial. Conditions studied include Pelvic Organ Prolapse and Prolapse.

CMS Open Payments shows 285 general payments to Ayman Mahdy from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Axonics, Inc. paid the most, $4,970.

Ayman Mahdy graduated from University of Assiut Faculty of Medicine in 1999.

Ayman Mahdy is in network with 22 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.